Old Web
English
Sign In
Acemap
>
authorDetail
>
A.P. Dyrbekk
A.P. Dyrbekk
Medicine
Mutant
egfr tki
Druggability
Cancer research
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P59.15 Is CD73 Expression a Druggable Mechanism of Resistance in EGFR-TKI-Treated EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)?
2021
Journal of Thoracic Oncology
Inger Johanne Zwicky Eide
A.P. Dyrbekk
Åslaug Helland
S. Ekman
Jussi Koivunen
Saulius Cicėnas
Bjørn Henning Grønberg
I. Bisha
T. Haberichter
S. Lakis
J. Chan
A. Lewis
P. Martin
Z. Cooper
Odd Terje Brustugun
Show All
Source
Cite
Save
Citations (0)
P59.18 Evaluation of ROS1 Expression in a Large Cohort of Early Stage Lung Cancer
2021
Journal of Thoracic Oncology
A.P. Dyrbekk
A. Warsame
Marius Lund-Iversen
P. Suhrke
Åslaug Helland
Odd Terje Brustugun
Show All
Source
Cite
Save
Citations (0)
1